| Patents for A61P 17 - Drugs for dermatological disorders (106,455) |
|---|
| 03/20/2001 | US6204059 AAV capsid vehicles for molecular transfer |
| 03/20/2001 | US6204047 Growth differentiation factor-10 |
| 03/20/2001 | US6204036 Stable, freeze dried mixture; parenteral administering |
| 03/20/2001 | US6203805 Topical compositions containing whey proteins |
| 03/20/2001 | US6203783 Use of alkyl polyglycosides and/or of O-acylated derivatives of glucose for treating hair loss |
| 03/20/2001 | CA2237979C Reduction of hair growth |
| 03/15/2001 | WO2001018236A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | WO2001018210A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | WO2001018181A2 Enzyme inhibitors |
| 03/15/2001 | WO2001018176A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001018172A2 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | WO2001018161A2 Process for the preparation of conjugated linoleic acid (cla) |
| 03/15/2001 | WO2001018040A2 Use of leptin in inhibition of endothelial cell proliferation |
| 03/15/2001 | WO2001018021A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | WO2001017995A1 Tyrosine kinase inhibitors |
| 03/15/2001 | WO2001017986A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | WO2001017953A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | WO2001017565A2 Polyoxyalkylenes conjugates as enzyme inhibitors |
| 03/15/2001 | WO2001017564A2 Enzyme inhibitors |
| 03/15/2001 | WO2001017558A2 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | WO2001017539A1 Herbal compositions for itchy or infected skin |
| 03/15/2001 | WO2001017531A1 Promotion of wound healing |
| 03/15/2001 | WO2001017523A1 Compositions and methods for modification of skin lipid content |
| 03/15/2001 | WO2001017519A1 Sunscreen agent for oral administration |
| 03/15/2001 | WO2001017508A1 Cationic liposome delivery of taxanes to angiogenic blood vessels |
| 03/15/2001 | WO2001017501A1 Enzyme inhibitors |
| 03/15/2001 | WO2001017498A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | WO2001017496A1 Skin-balance moisturizing cream |
| 03/15/2001 | WO2001017495A1 Skincare composition against free radicals |
| 03/15/2001 | WO2001017487A1 Chemical peeling agent |
| 03/15/2001 | WO2001017472A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | WO2001017374A1 Compositions comprising conjugated linoleic acid (cla) |
| 03/15/2001 | WO2000064468A3 Therapeutic compositions and methods for enhancing angiogenesis |
| 03/15/2001 | WO2000061604A3 Pharmaceutical compounds |
| 03/15/2001 | WO2000024419A8 Methods for enhancing wound healing |
| 03/15/2001 | DE19943553A1 Balsam for care and treatment of damaged skin, e.g. with wounds or ulcers, comprising carrier, e.g. St. John's wort oil, and herbal active agents, e.g. lavender, geranium and bergamot essences |
| 03/15/2001 | DE19942774A1 Zubereitungen zur oralen Aufnahme Preparations for oral administration |
| 03/15/2001 | CA2389916A1 B7-like polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2384679A1 Using quaternary ammonium salts for transdermal drug delivery |
| 03/15/2001 | CA2384101A1 Tyrosine kinase inhibitors |
| 03/15/2001 | CA2384099A1 Compositions and therapeutic methods involving isoflavones and analogues thereof |
| 03/15/2001 | CA2384089A1 Fibroblast growth factor-19 (fgf-19) nucleic acids and polypeptides and methods of use for the treatment of obesity |
| 03/15/2001 | CA2384076A1 Novel uses of mammalian ccr6 receptors and related reagents |
| 03/15/2001 | CA2384028A1 Use of conjugated linoleic acid (cla) for the topical treatment of cellulite |
| 03/15/2001 | CA2383790A1 Telomere restoration and extension of cell life-span in animals cloned from senescent somatic cells |
| 03/15/2001 | CA2383774A1 Fibroblast growth factor-like polypeptides |
| 03/15/2001 | CA2383086A1 Non-peptidic cyclophilin binding compounds and their use |
| 03/15/2001 | CA2382161A1 Immunoglobulin superfamily polynucleotides, polypeptides, and antibodies |
| 03/15/2001 | CA2381560A1 Skin-balance moisturizing cream |
| 03/14/2001 | EP1082956A1 Organogel comprising a hydrophilic oxidation-sensitive compound and its use, particularly in cosmetics |
| 03/14/2001 | EP1082456A1 Antisense modulation of cd40 expression |
| 03/14/2001 | EP1082320A1 Novel substituted imidazole compounds |
| 03/14/2001 | EP1082313A1 Bicyclic compounds, process for their preparation and pharmaceutical compositions containing them |
| 03/14/2001 | EP1082305A1 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 03/14/2001 | EP1082302A1 A vla-4 inhibitor: omepupa-v |
| 03/14/2001 | EP1082301A1 Ureas and carbamates of n-heterocyclic carboxylic acids and carboxylic acid isosteres |
| 03/14/2001 | EP1082298A2 1$g(a)-HYDROXY-25-ENE-VITAMIN D, ANALOGS AND USES THEREOF |
| 03/14/2001 | EP1082289A1 Methods for identifying novel multimeric agents that modulate receptors |
| 03/14/2001 | EP1082126A1 Novel peptides |
| 03/14/2001 | EP1082125A1 Pharmaceutical or cosmetic composition and method for cosmetic treatment of angiogenic disorders |
| 03/14/2001 | EP1082114A1 Hydroxyomeprazole compositions and uses |
| 03/14/2001 | EP1082111A1 Assay for identification of compounds that promote melanin production and retinoid-like compounds identified by said assay |
| 03/14/2001 | EP1082095A1 N-oxide of heterocyclic ester, amide, thioester or ketone hair growth compositions and uses |
| 03/14/2001 | EP1082028A1 Matthiola seed oil, mixtures containing it and use thereof |
| 03/14/2001 | EP1005333A4 Methods and compositions for preventing and treating chronological aging in human skin |
| 03/14/2001 | CN1287555A N-oxides of heterocyclic compounds with TNF and PDE IV inhibiting activity |
| 03/14/2001 | CN1286997A Antiphlogistic and analgesic ointment for treating rheumatism and trauma |
| 03/14/2001 | CN1286982A Body scenting skincare health medicine |
| 03/14/2001 | CN1063082C Medicine for removing wrinkles and eye bag and its preparing method |
| 03/14/2001 | CN1063079C Liquid agentia for treating superficial fungi diseases |
| 03/14/2001 | CN1063053C Burns and scalds medicinal oil |
| 03/13/2001 | US6201132 Inhibitors of membrane-bound serine protease; aminoacyl compounds |
| 03/13/2001 | US6201020 Effective poly(adenosine 5'-diphospho-ribose) polymerase (parp) inhibitor for treatment of tissue damage by necrosis or apoptosis; side effect reduction |
| 03/13/2001 | US6201019 Bi-aromatic compounds bound by a heteroethynylene radical and pharmaceutical and cosmetic compositions containing same |
| 03/13/2001 | US6200993 Heterosubstituted pyridine derivatives as PDE4 inhibitors |
| 03/13/2001 | US6200979 Administering substituted pyrazoles and pyzazolopyrimidines for treating phobias obsessive-compulsive disorder, post-traumatic stress disorder, single episode depression, recurrent depression, dysthymia, bipolar disorders |
| 03/13/2001 | US6200978 For preventing or treating inflammatory diseases such as arthritis, psoriasis, asthma, or inflammatory bowel disease, disorders of respiratory function, gastrointestinal disorders such as functional bowel disease, as analgesics |
| 03/13/2001 | US6200964 Silicone gel containing salicylic acid |
| 03/13/2001 | US6200957 Useful for treatment of variety of sex-hormone related and other conditions in both men and women |
| 03/13/2001 | US6200777 Human p101 polynucleotides |
| 03/13/2001 | US6200774 Compounds |
| 03/13/2001 | US6200587 Wound healing agents |
| 03/13/2001 | US6200570 Herbal formulation useful as a therapeutic and cosmetic applications for the treatment of general skin disorders |
| 03/13/2001 | CA2167651C Biologically highly active bicyclic aromatic compositions; pharmaceutical and cosmetic compositions containing the same and their use |
| 03/13/2001 | CA1341204C Analogues of igf-1 and igf-2 |
| 03/10/2001 | CA2282185A1 Oenothein medicaments |
| 03/08/2001 | WO2001016603A2 Analysis and treatment of body weight and eating disorders |
| 03/08/2001 | WO2001016345A2 Sequence-specific dna recombination in eukaryotic cells |
| 03/08/2001 | WO2001016319A2 Compositions and methods for the treatment of immune related diseases |
| 03/08/2001 | WO2001016293A2 Dna encoding the human serine protease t |
| 03/08/2001 | WO2001016290A2 Dna encoding the human serine protease eos |
| 03/08/2001 | WO2001016289A2 Zymogen activation system |
| 03/08/2001 | WO2001016288A2 Dna encoding the human serine protease c-e |
| 03/08/2001 | WO2001016178A1 MATERIALS AND METHODS FOR INHIBITION OF IgE PRODUCTION |
| 03/08/2001 | WO2001016170A2 Card proteins involved in cell death regulation |
| 03/08/2001 | WO2001016156A1 Attractin-like polynucleotides, polypeptides, and antibodies |
| 03/08/2001 | WO2001016139A1 Androgen receptor modulator compounds and methods |
| 03/08/2001 | WO2001016137A1 Compounds, methods and pharmaceutical compositions for treating cellular damage, such as neural or cardiovascular tissue damage |
| 03/08/2001 | WO2001016136A2 Tricyclic inhibitors of poly(adp-ribose) polymerases |
| 03/08/2001 | WO2001016135A2 Reverse-turn mimetics and methods relating thereto |